Switching rules determine when the model leaves one mode and enters another, while thresholds provide decision points based on changing clinical measurements. A continuously evolving physiological signal can therefore trigger a discrete change, such as a new symptom category or treatment decision. Adjusting these rules changes when transitions occur and can alter monitoring, simulation, and treatment-planning results.
Continuous measurements capture gradual biological change, whereas discrete states represent clinically meaningful categories, decisions, or transitions. Modeling them together preserves the relationship between a patient’s evolving physiology and the events that require action. This combination is important when a slowly changing signal can eventually cross a rule-defined boundary and produce a sudden change in clinical status or management.
The continuous part can represent physiological variables that change over time, while discrete modes represent stages, symptom categories, or other clinically distinct conditions. Rules connect these representations by specifying when a transition occurs. Researchers can use this structure to simulate gradual disease progression alongside sudden state changes, helping examine how interventions may influence the resulting clinical trajectory.
A clinical application begins by identifying continuously changing measurements and the discrete states or decisions that matter. Researchers then link them with rules or thresholds that specify mode changes. The resulting model can connect real-time measurements to actions, represent disease transitions, or simulate treatment scenarios. Its usefulness depends on whether the selected variables and transition rules reflect the clinical question.
They are useful when monitoring must translate changing physiological signals into discrete actions or device states. As measurements evolve, predefined rules can indicate when the system should recognize a symptom category, alter a treatment decision, or switch operating modes. This supports applications in patient monitoring and adaptive medical devices where timely responses depend on both ongoing signals and explicit events.
By linking physiological measurements with symptom categories and treatment decisions, the framework provides a structured way to examine clinical responses. It can support diagnosis by relating signals to discrete states, inform treatment planning through rule-based transitions, and simulate disease progression to evaluate interventions. These models are especially relevant when outcomes depend on gradual biological changes combined with sudden clinical events.